What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Asthma
- Disease
Ashley Woodcock mainly focuses on Asthma, Immunology, Allergy, Atopy and Internal medicine.
His Asthma research is multidisciplinary, incorporating elements of Anesthesia, Randomization, Placebo and Pediatrics.
Ashley Woodcock focuses mostly in the field of Immunology, narrowing it down to topics relating to Intensive care and, in certain cases, Confidence interval.
Ashley Woodcock interconnects Methacholine and Environmental exposure in the investigation of issues within Allergy.
The Atopy study combines topics in areas such as Nested case-control study and Risk factor.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Surgery.
His most cited work include:
- Two-, six-, and 12-minute walking tests in respiratory disease (1246 citations)
- Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma - A pilot study 164/rccm.200206-5250C (448 citations)
- Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood (391 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Asthma, Internal medicine, Immunology, Anesthesia and Allergy.
His research in Asthma intersects with topics in Corticosteroid, Randomized controlled trial and Pediatrics.
His Pediatrics research includes themes of Wheeze, Prospective cohort study and Cohort study.
His work focuses on many connections between Internal medicine and other disciplines, such as Surgery, that overlap with his field of interest in Lung and Respiratory disease.
His studies deal with areas such as Chronic cough and Placebo, Crossover study as well as Anesthesia.
In his work, Pyroglyphidae is strongly intertwined with Mite, which is a subfield of Allergen.
He most often published in these fields:
- Asthma (37.47%)
- Internal medicine (24.22%)
- Immunology (21.12%)
What were the highlights of his more recent work (between 2012-2021)?
- Asthma (37.47%)
- Internal medicine (24.22%)
- Anesthesia (22.98%)
In recent papers he was focusing on the following fields of study:
Ashley Woodcock mainly investigates Asthma, Internal medicine, Anesthesia, Fluticasone propionate and Randomized controlled trial.
His Asthma research is multidisciplinary, relying on both Odds ratio, Corticosteroid and Physical therapy.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Gastroenterology.
His Anesthesia research integrates issues from Capsaicin, Chronic cough and Placebo.
His Vilanterol study, which is part of a larger body of work in Fluticasone propionate, is frequently linked to Evening, bridging the gap between disciplines.
His study on Randomized controlled trial also encompasses disciplines like
- Exacerbation which intersects with area such as Clinical trial,
- COPD, which have a strong connection to Obesity,
- Intensive care medicine which connect with MEDLINE.
Between 2012 and 2021, his most popular works were:
- Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice (123 citations)
- Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial. (97 citations)
- Neurophenotypes in Airway Diseases. Insights from Translational Cough Studies. (64 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Asthma
His primary areas of study are Asthma, Anesthesia, Fluticasone propionate, Internal medicine and Vilanterol.
Ashley Woodcock has researched Asthma in several fields, including Physical therapy, Adverse effect and Randomized controlled trial.
His work deals with themes such as Capsaicin, Placebo and Chronic cough, which intersect with Anesthesia.
Ashley Woodcock combines subjects such as Dry-powder inhaler and Tolerability with his study of Fluticasone propionate.
His study looks at the relationship between Internal medicine and fields such as Sputum, as well as how they intersect with chemical problems.
His Fluticasone furoate/vilanterol study combines topics in areas such as Gastroenterology, Fluticasone and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
